Royalty Pharma plc
RPRX
Rang in Aktien
#893
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aktienkurs
$60.62
Marktkapitalisierung
$26.99B
Veränderung (1 Tag)
-0.56%
Veränderung (1 Jahr)
63.79%
Land
US
Handel Royalty Pharma plc (RPRX)
Kategorie
Healthcare
Dividendenhistorie für Royalty Pharma plc (RPRX)
Royalty Pharma plc (Aktienkürzel: RPRX) zahlte insgesamt 23 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: $4.50
Dividendenrendite (TTM): 0.0157
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: $4.50
Dividendenrendite (TTM): 0.0157
Dividendenzahlungen für Royalty Pharma plc (RPRX) von 2020 bis 2026
Jährliche Dividendenzahlungen
| Jahr | Dividende (angepasst an Aktiensplits) | ändert |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Liste aller Dividendenzahlungen
| Jahr | Dividende | ändert |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Dividendenzahlungen | Land |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 69.00% |
HK
|
